10.1002/ejoc.201601622
European Journal of Organic Chemistry
FULL PAPER
1H), 6.89 (d, J = 0.7 Hz, 1H), 6.03 (s, 1H), 4.09–4.01 (m, 2H), 3.98–3.90
(m, 2H). 13C-NMR (75 MHz, 1,4-dioxane-d8): C = 178.6, 144.0, 143.5,
143.3, 133.3, 132.4, 131.7, 130.6, 127.9, 124.1, 122.3, 120.1, 115.2, 111.7,
103.2, 100.8, 65.8 (2C). HRMS (ESI): m/z calcd for C18H12BrNO3S [M+H]+
401.9799, found 401.9807.
(15 mL) and extracted with ethyl acetate (2 × 15 mL). The organic phase
was dried over sodium sulphate and concentrated in vacuo. The crude
product was purified by flash column chromatography (silica gel, hexane
→ hexane/ethyl acetate 5:1) to give bromide 11 as a red oil. Yield 56%
(159 mg); 1H-NMR (300 MHz, CDCl3): H = 7.85 (d, J = 0.9 Hz, 1H), 7.75–
7.62 (m, 2H), 7.55 (d, J = 8.3 Hz, 1H), 7.39 (d, J = 8.8 Hz, 2H), 7.16 (s,
1H), 7.08 (d, J = 8.8 Hz, 4H), 6.98 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.8 Hz,
4H), 3.94 (t, J = 6.5 Hz, 4H), 1.78 (dt, J = 14.3, 6.5 Hz, 4H), 1.46 (br. s,
4H), 1.40 – 1.28 (m, 8H), 0.91 (t, J = 6.1 Hz, 6H). 13C-NMR (75 MHz,
CDCl3): C = 181.9, 155.7 (2C), 140.5 (2C), 137.2, 136.2, 133.2, 132.6,
130.9, 128.1, 127.0 (2C), 126.8 (4C), 125.1, 122.9, 120.4 (2C), 115.5,
115.3 (4C), 111.5, 111.3, 108.0, 68.3 (2C), 31.6 (2C), 29.7 (2C), 25.8 (2C),
22.6 (2C), 14.1 (2C). HRMS (ESI): m/z calcd for C41H44BrN2O3 [M+H]+
691.2535, found 691.2543.
5-(2-(4-(Bis(4-(hexyloxy)phenyl)amino)phenyl)-9-oxo-9H-pyrrolo[1,2-
a]indol-7-yl)thiophene-2-carbaldehyde (10). Under
a
nitrogen
atmosphere, to a solution of bromide 9 (0.17 g, 0.42 mmol) in degassed
dry N,N-dimethylformamide (5 mL) were added boronic ester 8 (0.48 g,
0.85 mmol), Pd(OAc)2 (5 mg, 0.02 mmol), dppf ligand (23 mg, 0.04 mmol),
copper(I) chloride (21 mg, 0.21 mmol) and dry cesium carbonate (0.55 g,
1.68 mmol). After being stirred for 16 h at 100 °C (TLC: hexane/ethyl
acetate 4:1) the mixture was quenched with distilled water (10 mL) and
extracted with ethyl acetate (3 × 10 mL). The organic phase was
concentrated (to approximately 5 mL) and water 1 (mL) and acetic acid
(100 μL) were added to deprotect the aldehyde. After stirring for 4 h the
phases were separated, the organic layer was washed with solution of 1%
NaHCO3/H2O (5 mL), dried over sodium sulphate and concentrated in
vacuo. The crude product was purified by flash column chromatography
(silica gel, hexane → hexane/ethyl acetate 5:1) to give aldehyde 10 as a
red amorphous solid. Yield: 40% (0.12 g); 1H-NMR (300 MHz, CDCl3): H
= 9.87 (s, 1H), 7.90–7.61 (m, 4H), 7.44–7.21 (m, 3H), 7.14 (d, J = 8.0 Hz,
1H), 7.10–6.97 (m, 5H), 6.93 (d, J = 8.0 Hz, 2H), 6.82 (d, J = 8.1 Hz, 4H),
3.93 (t, 6.0 Hz, 4H), 1.78 (dt, J = 12.9 Hz, 6.2 Hz, 4H), 1.59–1.40 (m, 4H),
1.40–1.11 (m, 8H), 0.91 (t, J = 5.5 Hz, 6H). 13C-NMR (75 MHz, CDCl3): C
= 182.6, 178.6, 155.6 (2C), 152.3, 148.2, 143.9, 142.6, 140.5 (2C), 137.4,
133.3, 132.6, 132.1, 131.0, 130.6, 126.6 (4C), 125.8 (2C), 124.9, 124.2,
122.0, 120.6 (2C), 115.4, 115.3 (4C), 111.6, 110.7, 68.3 (2C), 31.6 (2C),
29.3 (2C), 25.8 (2C), 22.6 (2C), 14.1 (2C). HRMS (ESI): m/z calcd for
C46H47N2O4S [M+H]+ 723.3257, found 723.3253.
5’-(2-(4-(Bis(4-(hexyloxy)phenyl)amino)phenyl)-9-oxo-9H-
pyrrolo[1,2-a]indol-7-yl)-2,2’-bithiophene-5 carbaldehyde (12). To a
solution of bromide 11 (150 mg, 0.25 mmol) in degassed toluene (5 mL)
was added boronic ester 9 (96 mg, 0.30 mmol) and the catalyst (Pd(PPh3)4,
17 mg, 0.015 mmol). The red coloured solution was stirred at room
temperature for 20 min, then a solution of sodium carbonate (0.185 g, 1.75
mmol) in degassed distilled water was added. The mixture was stirred at
80 °C for 48 h (TLC: hexane/ethyl acetate 3:1), quenched with distilled
water (15 mL) and extracted with ethyl acetate (2 × 15 mL). The organic
phase was dried over sodium sulphate and concentrated in vacuo. The
crude product was purified by flash column chromatography (silica gel,
hexane → hexane/ethyl acetate 5:1) to give aldehyde 12 as a crude
product. According to the 1H-NMR spectra the product contained just a
small amount of starting material 11 and thus it was used without further
purification in the next step. Yield 36% (0.071 g); 1H-NMR (300 MHz,
CDCl3): H = 9.87 (s, 1H), 7.82 (dd, J = 11.1, 1.7 Hz, 1H), 7.69 (d, J = 4.0
Hz, 2H), 7.67 (dd, J = 8.4, 1.8 Hz, 1H), 7.34 (d, J = 3.8 Hz, 1H), 7.31 (d, J
= 8.7 Hz, 2H), 7.28 (d, J = 7.4 Hz, 2H), 7.14 (d, J = 8.0 Hz, 1H), 7.06 (d, J
= 8.9 Hz, 4H), 7.02 (d, J = 5.2 Hz, 1H), 6.95 (d, J = 8.7 Hz, 2H), 6.83 (d, J
= 8.9 Hz, 4H) 3.94 (t, J = 6.5 Hz, 4H), 1.78 (quint, J = 6.7 Hz, 4H), 1.47
(quint, J = 7.2 Hz, 4H), 1.40–1.28 (m, 8H), 0.91 (t, J = 6.9 Hz, 6H). 13C-
NMR (126 MHz, CDCl3) C = 182.4, 178.9, 162.6, 155.5, 155.4, 148.0,
146.6, 144.3, 142.9, 141.7, 140.6, 140.5, 137.3, 132.9, 131.0, 126.6, 126.5,
125.7, 124.3, 124.2, 120.6, 120.5, 115.3, 115.3, 111.3, 111.1, 110.6, 110.5,
68.3, 31.6, 29.3, 25.8, 22.6, 14.1. HRMS (ESI): m/z calcd for C50H49N2O4S2
[M+H]+ 805.3133, found 805.3126.
3-(2-(4-(bis(4-(hexyloxy)phenyl)amino)phenyl)-9-oxo-9H-pyrrolo[1,2-
a]-indol-7-yl)thiophen-5-yl)-2-cyanoacrylate (HT157). Under a nitrogen
atmosphere, to a suspension of the protected aldehyde precursor 10 (0.13
g, 0.17 mmol) in acetic acid (1.50 mL) were added cyanoacetic acid (19
mg, 0.22 mmol), ammonium acetate (3 mg, 0.04 mmol) and chloroform (3
mL). The solution was refluxed for 10 h at 100 °C (TLC: hexane/ethyl
acetate 2:1). After cooling, the reaction mixture was extracted with
chloroform. The organic layer was dried over anhydrous Na2SO4. The
filtrate was concentrated under reduced pressure. Purification was
performed by recrystallization in ethanol to yield HT157 as a dark red
crystalline solid. Yield: 96% (0.125 g); mp: 202-203 °C; 1H-NMR (300 MHz,
DMSO-d6): H = 9.87 (1H, s), 8.42 (s, 1H), 8.04 (s, 1H), 7.94 (d, J = 4.5 Hz,
2H) 7.85–7.70 (m, 2H), 7.53 (d, J = 8.0 Hz, 1H), 7.41 (d, J = 8.1 Hz, 2H),
7.20 (s, 1H), 6.96 (d, J = 8.3 Hz, 4H), 6.86 (d, J = 8.3 Hz, 4H), 6.75 (d, J =
8.1 Hz, 2H), 3.90 (t, J = 6.0 Hz, 4H), 1.68 (dt, J = 13.2, 6.2 Hz, 4H), 1.45–
1.35 (m, 4H), 1.35–1.22(m, 8H), 0.87 (t, J = 5.4 Hz, 6H). 13C-NMR (75 MHz,
DMSO-d6): C = 177.8, 163.5, 157.0, 155.1 (2C), 147.2, 143.4, 140.8,
139.9 (2C), 132.5, 132.0, 131.6, 130.3, 129.8, 127.3, 126.5 (4C), 125.7,
125.7 (2C), 125.3, 125.0, 120.9, 119.7 (2C), 117.9, 116.7, 115.5, 115.4
(4C), 112.1, 111.3, 67.6 (2C), 31.0 (2C), 28.7 (2C), 25.2 (2C), 22.1 (2C),
13.9 (2C). HRMS (ESI): m/z calcd for C49H46N3O5S [M–H]– 788.3164,
found 788.3139.
3-(5’-(2-(4-(Bis(4-(hexyloxy)phenyl)amino)phenyl)-9-oxo-9H-
pyrrolo[1,2-a]-indol-7-yl)-2,2’-bithiophen-5-yl)-2-cyanoacrylate
(13,
piperidine salt of TA1314). To a suspension of aldehyde 12 (70 mg,
0.087 mmol) in dry acetonitrile (2.5 mL) were added cyanoacetic acid (40
mg, 0.47 mmol), piperidine (39 mg, 0.46 mmol, 45 μL) and chloroform (2
mL). The resulting solution was refluxed for 3 h and stirred overnight at
50 °C (TLC: hexane/ethyl acetate 2:1). The solvent was evaporated in
vacuo. The precipitated crystals were filtered off and washed with ice-cold
acetonitrile. Product 13 was isolated as a dark red solid. Yield: 74% (0.061
g); mp: 160-161 oC; 1H-NMR (500 MHz, CDCl3): H = 9.68 (br. s, 1H), 8.15
(s, 1H), 7.76 (dd, J = 9.0, 0.9 Hz, 1H), 7.62 (dd, J = 7.9, 1.3 Hz, 1H), 7.53
(d, J = 4.0 Hz, 1H), 7.28 (d, J = 8.8 Hz, 2H), 7.25 (s, 1H), 7.23 (d, J = 3.9
Hz, 1H), 7.17 (d, J = 3.9 Hz, 1H), 7.10 (d, J = 8.2 Hz, 1H), 7.05 (d, J = 8.9
Hz, 4H), 6.98 (s, 1H), 6.93 (d, J = 8.2 Hz, 2H), 6.82 (d, J = 8.9 Hz, 4H),
3.93 (t, J = 6.5 Hz, 4H), 3.30 (s, 1H), 3.21–3.14 (m, 4H), 2.01 (s, 1H), 1.93–
1.83 (m, 4H), 1.78 (dt, J = 14.5, 6.6Hz, 4H), 1.68 (br. s, 2H), 1.47 (quint, J
= 7.1 Hz, 4H), 1.39–1.32 (m, 8H), 0.91 (t, J = 6.8 Hz, 6H). 13C-NMR (75
MHz, CDCl3): C = 179.0, 168.1, 158.1, 155.5, 147.3 (2C), 143.5, 141.0,
140.6 (2C), 135.8, 132.9, 132.4, 130.9, 130.1, 129.6, 127.4, 126.6 (4C),
126.5, 125.8, 125.8 (2C), 125.4, 125.2, 124.1, 121.3, 120.7 (2C), 119.7,
118.5, 116.9, 116.3, 115.3 (4C), 112.9, 111.4, 68.3 (2C), 44.4 (2C), 31.6
(2C), 29.4 (2C), 27.4 (2C), 25.8 (2C), 22.7, 22.6 (2C), 14.1 (2C). HRMS
2-(4-(Bis(4-(hexyloxy)phenyl)amino)phenyl)-7-bromo-9H-pyrrolo[1,2-
a]indol-9-one (11). Under a nitrogen atmosphere, to a solution of
fluorazone 5a (175 mg, 0.47 mmol) in degassed dry tetrahydrofuran (3 mL)
were added Pd(PPh3)4 (35 mg, 0.03 mmol), distilled and degassed water
(1.5 mL) and dry potassium carbonate (195 mg, 1.41 mmol). The
suspension was stirred for 30 min at 40 °C before being treated with a
solution of boronic ester 8 (0.32 g, 0.56 mmol) in degassed dry
tetrahydrofuran (3 mL). After being stirred for 24 h at 80 °C (TLC:
hexane/ethyl acetate 3:1) the mixture was quenched with distilled water
This article is protected by copyright. All rights reserved.